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Traditional Chinese medicine (TCM) syndrome is an important basis for TCM diagnosis and treatment. As Child-Pugh
classiﬁcation as well as compensation and decompensation phase in liver cirrhosis, it is also an underlying clinical classiﬁcation. In
this paper, we investigated the correlation between single nucleotide polymorphisms (SNPs) of Interleukin-10 (IL-10) and TCM
syndromesinpatientswithhepatitisBcirrhosis(HBC).Sampleswereobtainedfrom343HBCpatientsinChina.ThreeSNPsofIL-
10 (−592A/C, −819C/T, and −1082A/G) were detected with polymerase chain-reaction-ligase detection reaction (PCR-LDR).The
result showed the SNP-819C/T was signiﬁcantly correlated with Deﬁciency syndrome (P = 0.031), but none of the 3 loci showed
correlation either with Child-Pugh classiﬁcation and phase in HBC patients. The logistic regression analysis showed that the
Excess syndrome was associated with dizzy and spider nevus, and the Deﬁciency syndrome was associated with dry eyes, aversion
to cold, IL-10-819C/T loci, and IL-10-1082A/G loci. The odds ratio (OR) value at IL-10-819C/T was 4.022. The research results
suggested that IL-10-819C/T locus (TC plus CC genotype) is probably a risk factor in the occurrence of Deﬁciency syndrome in
HBC patients.
1.Introduction
Hepatitis B virus (HBV) infection is a major health problem
in China. It is one of the major causes of virus-related
liver diseases such as liver cirrhosis (LC) and hepatocellular
carcinoma(HCC)[1,2].Thereare350millionHBV-infected
people aroundthe world, about15–25% of whohave therisk
of dying of the HBV-caused LC and HCC [3]. During the
course of HBV infection, liver is gradually damaged by this
hepatotropic DNA virus, presenting a wide variety of clinical
manifestations ranging from an asymptomatic carrier state
to chronic hepatitis B (CHB), and to HBC, even to HCC
[2,4].Five-yearsurvivalrateofpatientswithsevereCHBand
HBC is about 50% [5–7]. Whether chronic HBV infection
would be developed to CHB or even LC, the process is
aﬀected by many factors such as hereditary susceptibility of
patients.
DNAsequenceanditsvariationsarereﬂectingthehuman
evolutionary process. SNP is a variation occurring when a
single nucleotide in the genome (or other shared sequence)
diﬀers between members of a biological species or paired
chromosomes in an individual [8]. It can help us to
understand the occurrence and development of human
diseases, and the response to drug therapy. Currently, it is
known that at least 93% of human genes could present SNPs
[9], and the SNPs have become the research focus of genetic
susceptibility, and in the process of infectious diseases [10].
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hereditary susceptibility of gene and liver disease, such as
SNPs of aldehyde dehydrogenase 2 (ALDH2) and HCC [11],
interleukin-2 (IL-2), IFN-γ, IL-10 and the infection of HBV,
HCV,orHBV/HCVcoinfection[12].However,thestudiesof
the correlation between genetic susceptibility and HBC are
quite few.
The classiﬁcation of disease is an important basis for the
diagnosis of disease. In the LC, the phenotypes have been
used to the classiﬁcation, such as Child-Pugh classiﬁcation,
compensation and decompensation phase, hepatocellular
function, and traditional Chinese medicine (TCM) syn-
dromes. The TCM syndrome, also called ZHENG or TCM
pattern, is the basic unit and the key concept in TCM theory.
All diagnostic and therapeutic methods in TCM are based on
thediﬀerentiationofZHENG[13].ZHENGisanabstraction
of TCM theory, which can be seen as a simply assemblage of
disease symptoms.
In this study, we investigated the correlation between
the IL-10 gene SNPs and phenotypes, which include TCM
syndromes, Child-Pugh classiﬁcation, and compensation or
decompensation phase in HBC patients.
2.MaterialsandMethods
2.1. Patients and Samples. In this study, 343 patients
were recruited from Longhua Hospital, Shuguang Hospital,
Yueyang Hospital and Putuo Hospital in Shanghai, the
First Aﬃliated Hospital of Henan University of TCM and
Ruikang Hospital in Guangxi in China. The patients were
selected based on their age, gender, disease classiﬁcation
and area distribution (Table 1). All patients were Chinese
yellow race. Blood samples were obtained from all subjects
with informed consent and approved by ethic committee in
respective hospitals, based on the Declaration of Helsinki.
Each subject donated 3mL peripheral blood samples, which
were collected and stored at −80◦C before DNA extraction.
2.2. Child-Pugh, Phase, and TCM Syndrome. The patients
were divided into class A, class B, and class C according to
Child-Pugh-Turcotte (CPT) score, and the CPT score was
calculated by rating the following ﬁve parameters including
serum levels of bilirubin and albumin, prothrombin time,
ascites, and encephalopathy [14, 15]. According to clinical
symptoms of patients and development of the disease,
liver cirrhosis was divided into compensation phase and
decompensation phase.
The clinical information of HBC patients such as symp-
toms and signs was collected from the above 6 hospitals,
and then TCM syndromes were classiﬁed into Excess,
Deﬁciency, and Deﬁciency-Excess syndromes by 3 TCM
senior physicians according to the deﬁne of diagnosis, and
TCM syndrome diﬀerentiation of liver cirrhosis [16]. The
Excess syndrome was including Liver-qi stagnation syn-
drome, Damp-heat syndrome, and Blood stasis syndrome.
The Deﬁciency-Excess syndrome was Damp abundance and
spleen asthenia syndrome. The Deﬁciency syndromes were
including liver-kidney yin deﬁciency syndrome and Yang
deﬁciency of spleen and kidney syndrome.
Table 1: Clinical data of 343 HBC patients.
Gender No (%)
Male 242 (70.55)
Female (%) 101(29.45)
Mean age (yr) 49.57 ±10.02
Child-Pugh-Turcotte score (%)
A 240 (69.97)
B 75 (21.87)
C 28 (8.16)
Phase (%)
Compensation phase 203 (59.18)
Decompensation phase 140 (40.82)
Area (%)
Shanghai 226 (65.89)
Guangxi 69 (20.12)
Henan 48 (13.99)
2.3. DNA Extraction. Blood samples of all the patients were
collected in K2EDTA tubes. Genomic DNA was selected
from 1mL peripheral blood of each sample, using the
TIANampBloodDNAKit(TiangenBiotech,Beijing,China).
Subsequently, the DNA was stored at −80◦C for following
genotype analysis.
2.4. SNP Genotyping. Firstly, the genomic DNA extracted
from clinical samples was subjected to a multiplex PCR
(Invitrogen, Carlsbad, CA). Brieﬂy, 1μL of genomic DNA
was added to a 15uL ﬁnal volume containing 0.25μLp e r
primer (10μmol/L) (prime sequence in Table 2), 0.2μLT a q
enzyme,1.5μL10×PCRbuﬀer,0.3μLdNTPs(2.5mmol/L),
1.5uL Mgcl2 and 10uL deionized water. The reaction
mixture was followed by a denaturation step at 94◦Cf o r
2min and 35 cycles of ampliﬁcation (94◦C for 20s, 60◦Cf o r
20s, and 72◦C for 40s) with a ﬁnal extension step at 72◦Cf o r
3min through ABI 9600 (Applied Biosystems).
Secondly, LDR assays were carried out using conditions
similar to those described elsewhere with slight modiﬁca-
tions [17]. Brieﬂy, the ﬁnal volume containing 2uL PCR
products, 1uL 10 × Taq DNA ligase buﬀer, 0.125uL Taq
DNA ligase (40U/uL, New England Biolabs, Beverly, MA)
and 0.01μL per probe (10bp) and 6.845μL deionized water.
LDR probes were designed by the Generay Biotechnology
Company (probes sequence in Table 3). LDR mixtures were
thermally cycled for 20 cycles of 30s at 94◦C and 3min at
64◦C through ABI 9600 (Applied Biosystems).
Lastly, the mixture of 1μL LDR product and 2μL loading
Dye was followed by a denaturation step at 95◦Cf o r3m i n
and was immediately put into ice-water. Then, the products
were detected by ABI 3730XL DNA sequencer (Applied
Biosystems).
Additionally, about 5% of the samples were randomly
selected and retested by direct DNA sequencing in Shanghai
NationalBiochipResearchCenterLaboratory,andtheresults
were concordant with PCR-LDR.Evidence-Based Complementary and Alternative Medicine 3
Table 2: The gene position, polymorphism, primer sequences, and gene frequencies of IL-10 SNPs.
Gene position Rs number Polymorphism Primer sequence Gene frequencies (%)
IL-10-592 A/C rs1800872 A/C F:AAGAGGTGGAAACATGTGCC 22.20
R:TACCCAAGACTTCTCCTTGC
IL-10-819 C/T rs1800871 C/T F:ATGGTGTACAGTAGGGTGAG 57.70
R:TTTCCACCTCTTCAGCTGTC
IL-10-1082 A/G rs1800896 A/G F:AGAAGTCCTGATGTCACTGC 15.10
R:AAGTCAGGATTCCATGGAGG
Table 3: The LDR probes for IL-10 detection.
Gene position Probes sequence
IL-10-592 A/C
A60-S7-TA: TTTTTTTTAACACATCCTGTGACCCCGCGTGTA
A60-S7-TC: TTTTTTTTTTTAACACATCCTGTGACCCCGCGTGTC
A60-S7-TR: -P-CTGTAGGAAGCCAGTCTCTGGAAAGTTTTTT-FAM-
IL-10-819 C/T
A60-S6-TC: TGTACCCTTGTACAGGTGAAGTAAC
A60-S6-TT: TTTTGTACCCTTGTACAGGTGAAGTAAT
A60-S6-TR: -P-ATCTCTGTGCCTCAGTTTGCTCACT-FAM-
IL-10-1082 A/G
A60-S5-TA: AACACTACTAAGGCTTCTTTCGGAA
A60-S5-TG: TTTAACACTACTAAGGCTTCTTTCGGAG
A60-S5-TR: -P-GGGGAAGTAGGGATAGGTAAGAGGA-FAM-
2.5. Statistical Analysis. The data determined by the fre-
quencyofgenotypeobeyedtheHardy-Weinbergequilibrium
(HWE) between the observed and expected genotype values.
The correlation between genotypes and phenotypes was
comparedbytheX2 test.P<0.05wasconsideredstatistically
signiﬁcant in all tests. A binary logistic regression analysis
wasusedfortheevaluationoftheindependenteﬀectofIL-10
SNPs on the TCM symptoms of HBC. Odds ratio (OR) and
95% conﬁdence interval (CI) were rated.
3. Results
3.1. Characteristics of the Study Population. The frequencies
of 3 SNPs loci of IL-10 were assessed in 343 HBC patients
in China. The Hardy-Weinberg equilibrium (HWE) test
showed that the distribution of these tested genotypes was
not signiﬁcantly diﬀerent from the expected distribution
(P>0.05) (Table 1). The ages of patients ranged from 18
to 65 years old (mean ± SD, 49.57 ± 10.02). There were no
signiﬁcant diﬀerences of age and sex in gene polymorphisms
in research object (P>0.05). Males were 242 (70.55%)
and females were 101 (29.45%). In Child-Pugh classiﬁcation,
class A, class B, and class C were 240 (69.97%), 75 (21.87%),
and 28 (8.16%), respectively. There were 203 (59.18%) in
compensation phase and 140 (40.82%) in decompensation
phase.
3.2. Correlation between IL-10 Genotypes and Child-Pugh
Classiﬁcation and Compensation or Decompensation Phase
in HBC Patients. As shown in Table 4, there was no sig-
niﬁcant correlation between IL-10 genotypes and Child-
Pugh classiﬁcation in HBC patients. It showed that the
P value was greater than 0.05 between IL-10 genotypes
(−592A/C, −819C/T, and −1082A/G) and class A, class B
and class C of Child-Pugh classiﬁcation, respectively. Also,
there was no signiﬁcant correlation between IL-10 genotypes
(−592A/C, −819C/T, and −1082A/G) and compensation or
decompensation phase, respectively (P>0.05).
3.3. Correlation between IL-10 Genotypes and TCM
Syndromes in HBC Patients. The correlation was analyzed
between IL-10 genotypes (−592A/C, −819C/T, and
−1082A/G) and TCM syndromes in HBC patients. As
shown in Table 5, TC plus CC genotype of IL-10-819C/T was
signiﬁcantlydiﬀerentwithTTgenotype(P = 0.031)between
Deﬁciency syndrome and other TCM syndromes. However,
there was no signiﬁcant correlation between IL-10-592A/C
and −1082A/G genotypes and TCM syndromes (P>0.05).
It indicated that the patients with TC plus CC genotype of
IL-10-819C/T may be appearance of Deﬁciency syndrome.
3.4. Correlation between the TCM Syndromes and Clinical
Data and IL-10 SNPs in HBC Patients. To further clarify
the correlation between Excess syndrome or Deﬁciency
syndrome and clinical data and IL-10 SNPs in HBC patients,
the binary logistic regression analysis was carried out. The
analytic parameters were including age, gender, IL-10 SNPs
loci (−592A/C, −819C/T, and −1082A/G), clinical symp-
tomsandsigns(fatigue,poorappetite,abdominaldistension,
backache, limp aching knees, dry eyes, dizzy, pruritus, yellow
urine,aversiontocold,loosestools,spidernevus,ascites)and
hepatocellular function parameters (ALT, AST, bilirubin and
albumin, prothrombin time). The results showed that the
Excess syndrome was associated with dizzy and spider nevus
(Table 6), and the Deﬁciency syndrome was associated with
dry eyes, aversion to cold, IL-10-819C/T, and −1082A/G loci4 Evidence-Based Complementary and Alternative Medicine
Table 4: Correlation between IL-10 genotypes and Child-Pugh classiﬁcation or compensation and decompensation phase in HBC patients.
Gene/genotype
Child-Pugh classiﬁcation
P
Phase
P
Class A (%)
(n = 240)
Class B (%)
(n = 75)
Class C (%)
(n = 28)
Compensation
(n = 203)
Decompensation
(n = 140)
IL-10-592 A/C
AA 104 (43.7) 35 (46.7) 13 (46.4)
0.839
83 (40.9) 69 (50.0)
0.072 AC 108 (45.4) 35 (46.7) 13 (46.4) 95 (46.8) 61 (44.2)
CC 26 (10.9) 5 (6.7) 2 (7.1) 25 (12.3) 8 (5.8)
IL-10-819C/T
TT 114 (47.5) 36 (48.0) 12 (42.9)
0.770
90 (44.3) 72 (51.4)
0.076 CT 103 (42.9) 32 (42.7) 15 (53.6) 89 (43.8) 61 (43.6)
CC 23 (9.6) 7 (9.3) 1 (3.6) 24 (11.8) 7 (5.0)
IL-10-1082A/G
AA 212 (88.3) 65 (86.7) 22 (78.6)
0.340∗ 182 (89.7) 177 (88.5)
0.710∗ AG 27 (11.3) 10 (13.3) 6 (21.4) 20 (9.9) 23 (11.5)
GG 1 (0.4) 0 (0) 0 (0) 1 (0.5) 0 (0)
∗Between AA and AG + GG of IL-10-1082A/G.
Table 5: Correlation between IL-10 genotypes and TCM syndromes in HBC patients.
TCM syndrome type IL-10-592 P IL-10-819 P IL-10-1082 P
AA AC + CC TT TC + CC GG AG + AA
Excess syndrome 197 29 0.999 111 112 0.600 22 203 0.969
Deﬁciency-Excess syndrome 41 7 0.735 27 24 0.470 4 49 0.621
Deﬁciency syndrome 61 8 0.778 23 46 0.031 7 56 0.726
Total 299 44 163 180 33 308
∗X
2 test.
(Table 6). The odds ratio (OR) value at IL-10-819C/T was
4.022. It further indicated that IL-10-819C/T locus (TC plus
CC genotype) is probably a very high risk in the occurrence
of Deﬁciency syndrome in HBC patients.
4. Discussion
TCM syndrome classiﬁcation, also deﬁned as ZHENG dif-
ferentiation, is the basic concept in the TCM theory. TCM
syndrome, a proﬁle of symptoms and signs as a series of
clinical phenotypes, plays an important role in understand-
ing the human homeostasis and guiding the applications
of TCM treatment. All diagnostic and therapeutic methods
in TCM are based on the diﬀerentiation of the TCM
pattern, and this concept has been used for thousands of
years in China [18]. The “Heat,” “Cold,” “Excess,” and
“Deﬁciency” are the four basic syndromes in TCM [19]. In
TCM practice, an experiential diagnosis approach has been
frequentlyusedtoclassifyExcess,Deﬁciency,andDeﬁciency-
Excess syndrome in HBC patients. In order to replace the
traditional experiential diagnosis, the scientiﬁc evidence for
TCM syndrome classiﬁcation is essential, and it would be
beneﬁcial to understand the classiﬁcation and essence of the
TCM syndrome.
IL-10 is an important immunoregulatory cytokine
mainly produced by activated T cells, monocytes, B cells,
and thymocytes. As an immune response modulator, IL-10
can both stimulate and suppress the immune response [20].
Several polymorphic sites of IL-10 gene promoter region
havebeendescribed,includingthreebiallelicpolymorphisms
at positions −1082A/G, −819C/T, and −592A/C from the
transcription start site. The IL-10-819C/T C and T alleles
were completely in linkage disequilibrium with the IL-10-
592A/C A and C alleles, respectively. The −592A allele was
exclusively associated with the −1082A allele. These result
in three diﬀerent haplotypes: GCC, ACC, and ATA [21]. It
has been reported that IL-10 gene SNP was associated with
several diseases such as breast cancer [22], cervical cancer
[23], multiple myeloma [24], and gastric carcinoma [25].
Moreover, IL-10 promoter polymorphism was associated
with the progression of HBV infection [26].
Previous studies have shown that TCM syndrome is
associated with gene SNPs. For example, the people with 5-
HTTLPR SS genotype polymorphism may be the susceptible
population of Excess of liver Yang syndrome [27]. The K
allele of ABCA1 gene may be protective factors of phlegm
syndrome and blood stasis syndrome in coronary heart
disease [28]. The kidney-Yang Deﬁciency syndrome (KDS)
is closely related with special SNP linkage disequilibrium
in the intragenic level, and genes within the ﬂanks of these
SNPs suggest some essential symptoms of KDS [29]. There
was correlation between liver-qi stagnation syndrome and
gene polymorphism of tryptophan hydroxylase (TPH) and
G-proteinβ3 submit (GNB3) in HBC patients [30]. We haveEvidence-Based Complementary and Alternative Medicine 5
Table 6: Correlation between Excess or Deﬁciency syndrome and clinical data and IL-10 gene SNPs in HBC patients.
Factors B SE Wald P OR 95%CI
Lower Upper
Excess syndrome
Abdominal distension 0.277 0.148 3.509 0.061 1.319 0.987 1.763
Dizzy 0.658 0.203 10.458 0.001 1.931 1.296 2.876
Spider nevus 0.385 0.180 4.594 0.032 1.469 1.033 2.089
Constant 0.173 0.199 0.755 0.385 1.189
Deﬁciency syndrome
Dry eyes 0.448 0.191 5.518 0.019 1.566 1.077 2.276
Aversion to cold 0.605 0.203 8.868 0.003 1.830 1.230 2.725
IL-10-819C/T 1.392 0.442 9.921 0.002 4.022 1.692 9.563
IL-10-1082A/G −0.903 0.430 4.415 0.036 0.406 0.175 0.941
Constant −1.163 0.777 2.240 0.134 0.313
been investigated some cytokine such as TNF-α,T G F - β1,
and IL-10 [31] and further found that IL-10 genotype may
correlate with TCM syndrome in HBC patients [32].
In this study, therefore, to further investigate whether
IL-10 genotypes correlated really to TCM syndromes, more
samples from diﬀerent area (Shanghai, Henan and Guangxi
in China) were applied, compared to Child-Pugh classiﬁ-
cation and compensation or decompensation phase. The
results showed that IL-10-819C/T locus was signiﬁcantly
correlated to Deﬁciency syndrome (P = 0.031), and IL-
10 gene loci (−592A/C, −819C/T, and −1082A/G) were
not correlated to either Child-Pugh classiﬁcation or com-
pensation and decompensation phase in HBC patients. The
binary logistic regression analysis showed that the Deﬁciency
syndrome was associated with dry eyes, aversion to cold, IL-
10-819C/TandIL-10-1082A/Glocus,andORvalueatIL-10-
819C/T was 4.022. The research results suggested that IL-10-
819C/T locus (TC plus CC genotype) might correlate with
the risk in the occurrence of Deﬁciency syndrome in HBC
patients. The study provided a proof for TCM syndrome
classiﬁcation, which would be helpful to the TCM clinical
diagnosis in HBC patients.
Though our results showed that IL-10 genotype might
correlate with Deﬁciency syndrome in HBC patients, it is
diﬃcult to understand the relationship between IL-10 SNPs
and TCM syndromes, while TCM syndrome changes follow-
ing patient’s condition and disease situation. In recent years,
following the implementation of Human Genome Project
and high throughput Genomic strategies, a large number
of human complex diseases associated genetic variants have
been identiﬁed through Genome-wide association studies
(GWAS) [33]. To discover genetic base of TCM syndrome
changes as well as other phenotypes of diseases, the GWAS
method might provide important clues in future research.
5. Conclusion
In this study, we identiﬁed that IL-10-819C/T locus was
signiﬁcantly correlated to Deﬁciency syndrome, and the OR
valuewas4.022,andindicatedthatHBCpatientswiththeCC
genotype plus TC genotype at IL-10-819C/T might correlate
with the risk in the occurrence of Deﬁciency syndrome.
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